The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients
Clinical trial NCT04776889 · COMPLETED
Trial details
- NCT number
- NCT04776889
- Sponsor
- National Cancer Institute, Egypt
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-15
- Primary completion
- 2020-12-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.